Solesence, Inc. (SLSN)
| Market Cap | 92.53M -53.1% |
| Revenue (ttm) | 62.06M +18.6% |
| Net Income | 1.79M -57.7% |
| EPS | 0.02 -70.6% |
| Shares Out | 70.63M |
| PE Ratio | 65.50 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 23,185 |
| Open | 1.250 |
| Previous Close | 1.210 |
| Day's Range | 1.250 - 1.350 |
| 52-Week Range | 0.780 - 16.560 |
| Beta | 1.17 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | May 4, 2026 |
About SLSN
Solesence, Inc., a science-driven company, provides engineered materials, formulation development, and commercial manufacturing services in the United States. The company engages in the manufacture and supply of surface engineered zinc oxide and titanium dioxide ingredients. It also provides skin care formulations with mineral-based UV protection enabled by proprietary active pharmaceutical ingredients; and skin health products, such as sunscreens and daily care products. The company sells products in various markets, including medical diagnost... [Read more]
Financial Performance
In 2025, Solesence's revenue was $62.06 million, an increase of 18.56% compared to the previous year's $52.35 million. Earnings were $1.79 million, a decrease of -57.73%.
Financial StatementsNews
Solésence Reports Fourth Quarter and Full-Year 2025 Financial Results
Full Year 2025 record revenue of $62.1 million ROMEOVILLE, Ill., March 31, 2026 (GLOBE NEWSWIRE) -- Solésence, Inc. (Nasdaq: SLSN), a leader in scientifically-driven health care solutions across beaut...
Solésence To Report Fourth Quarter and Full Year 2025 Financial Results and Host a Conference Call on March 31, 2026
ROMEOVILLE, Ill., March 19, 2026 (GLOBE NEWSWIRE) -- Solésence, Inc. (Nasdaq: SLSN), a leader in scientifically-driven health care solutions across beauty and life science categories, today announced ...
Yoolie Park joins Solésence, Inc. as Vice President of Brand Partnerships
Park brings over 20 years of industry experience to expand innovation and drive brand partner growth ROMEOVILLE, Ill., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Solésence, Inc. (Nasdaq: SLSN) a leader in scie...
Solésence Reports Third Quarter 2025 Financial Results
Advances Strategic Transformation with Key Changes in Executive Leadership, Product Development and Operations ROMEOVILLE, Ill., Nov. 11, 2025 (GLOBE NEWSWIRE) -- Solésence, Inc. (Nasdaq: SLSN), a lea...
Solésence, Inc. Appoints Yoana Dvorzsak as Vice President of Innovation and Product Integrity
Dvorzsak to oversee product quality and drive innovation to support growth amidst evolving consumer needs; Named a Cosmetic Executive Women (CEW) Innovator Honoree ROMEOVILLE, Ill., Nov. 10, 2025 (GLO...
Solésence To Report Third Quarter 2025 Financial Results and Host a Conference Call
ROMEOVILLE, Ill., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Solésence, Inc. (Nasdaq: SLSN), a leader in scientifically-driven health care solutions across beauty and life science categories, today announced t...
Solésence Announces Key Leadership Appointments to Drive Future Innovation and Growth
ROMEOVILLE, Ill., Sept. 03, 2025 (GLOBE NEWSWIRE) -- Solésence, Inc. (Nasdaq: SLSN), a leader in scientifically-driven health care solutions across beauty and life science categories, today announced ...
Solésence Reports Second Quarter 2025 Financial Results
ROMEOVILLE, Ill., July 31, 2025 (GLOBE NEWSWIRE) -- Solésence, Inc. (Nasdaq: SLSN), a leader in scientifically-driven health care solutions across beauty and life science categories, today announced f...
Solésence To Report Second Quarter 2025 Financial Results and Host a Conference Call
ROMEOVILLE, Ill., July 24, 2025 (GLOBE NEWSWIRE) -- Solésence, Inc. (Nasdaq: SLSN), a leader in scientifically-driven health care solutions across beauty and life science categories, today announced t...
Solésence to Join Russell 3000® and Russell 2000® Indexes
ROMEOVILLE, Ill., June 24, 2025 (GLOBE NEWSWIRE) -- Solésence, Inc. (Nasdaq: SLSN), a leader in scientifically-driven health care solutions across beauty and life science categories, today announced t...
Solésence Expands Debt Facilities to Fuel Growth Initiatives
ROMEOVILLE, Ill., June 02, 2025 (GLOBE NEWSWIRE) -- Solésence, Inc. (Nasdaq: SLSN), a leader in scientifically-driven health care solutions across beauty and life science categories, today announced t...
Solésence Reports Record First Quarter 2025 Financial Results
First quarter revenue increased 48% to a record $14.6 million ROMEOVILLE, Ill., May 05, 2025 (GLOBE NEWSWIRE) -- Solésence, Inc. (Nasdaq: SLSN), a leader in scientifically-driven health care solutions...
Solésence To Report First Quarter 2025 Financial Results and Host a Conference Call
ROMEOVILLE, Ill., April 28, 2025 (GLOBE NEWSWIRE) -- Romeoville, Ill., April 28, 2025 – Solésence, Inc. (Nasdaq: SLSN), a leader in scientifically-driven health care solutions across beauty and life s...
Solésence Announces Uplisting to Nasdaq
Trading set to begin Tuesday, April 8 under new ticker “SLSN” ROMEOVILLE, Ill., April 07, 2025 (GLOBE NEWSWIRE) -- Solésence, Inc. (OTCQB: NANX), a leader in scientifically-driven health care solution...
Solésence Reports Record Fourth Quarter and Full-Year 2024 Financial Results
Fourth quarter revenue increased 58% to a record $12.6 million Full Year 2024 revenue increased 40% to a record $52.3 million ROMEOVILLE, Ill., March 26, 2025 (GLOBE NEWSWIRE) -- Solésence, Inc. (OTCQ...
Solésence To Report Fourth Quarter and Full Year 2024 Financial Results and Host a Conference Call
ROMEOVILLE, Ill., March 20, 2025 (GLOBE NEWSWIRE) -- Solésence, Inc. (OTCQB: NANX), a leader in scientifically-driven health care solutions across beauty and life science categories, today announced t...
Solésence Wins Best Prestige Finished Formula at the 2025 Cosmetics & Toiletries Allē Awards, Marking Third Consecutive Win
ROMEOVILLE, Ill., March 13, 2025 (GLOBE NEWSWIRE) -- Solésence, Inc. (OTCQB: NANX), a leader in scientifically-driven health care solutions across beauty and life science categories, today announced t...
Solésence Launches New Investor Relations Website
ROMEOVILLE, Ill., March 12, 2025 (GLOBE NEWSWIRE) -- Solésence, Inc. (OTCQB: NANX), a leader in scientifically-driven health care solutions across beauty and life science categories, today announced t...
Nanophase Technologies Rebrands as Solésence, Elevating the Future of Skin Health
ROMEOVILLE, Ill., March 07, 2025 (GLOBE NEWSWIRE) -- Nanophase Technologies Corporation (OTCQB: NANX), a leader in mineral-based and scientifically-driven health care solutions across beauty and life ...
Nanophase Reports Record Third Quarter Revenue and Profit
—Nanophase Reports Q3 Revenue Record at $16.9 Million with Solésence Revenue up 171% YOY
Nanophase Technologies Announces Third Quarter 2024 Financial Release and Conference Call Details
Romeoville, Ill., Oct. 24, 2024 (GLOBE NEWSWIRE) -- Nanophase Technologies Corporation (OTCQB: NANX), a leader in mineral-based and scientifically-driven health care solutions across beauty and life s...
System1 And 2 Other Stocks Under $2 Executives Are Buying
The Dow Jones index closed higher by more than 1% on Monday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects.
Nanophase Reports Record Second Quarter Revenue and Profit
—$13 Million in Q2 Revenue, with Solésence Revenue up 44% YOY —$1.7 Million in Profit for the First Half of 2024 alongside Record Q2 Profit —Record Third Win in a Row at Cosmoprof and Cosmopack ...
Nanophase Technologies Announces Second Quarter 2024 Financial Release and Conference Call Details
Romeoville, Ill., July 29, 2024 (GLOBE NEWSWIRE) -- Nanophase Technologies Corporation (OTCQB: NANX), a leader in mineral-based and scientifically-driven health care solutions across beauty and life s...
Solésence Beauty Science Wins Cosmopack North America Formulation Award for Third Year in a Row
Solésence is the first and only third-time winner of the Awards in the Cosmoprof North America network Solésence is the first and only third-time winner of the Awards in the Cosmoprof North America ne...